Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects.
Background: Inhaled LPS causes neutrophilic airway inflammation in healthy subjects. We compared the effects of p38 MAPK inhibitors and fluticasone propionate on the LPS response. Methods: Three randomised, double-blind, placebo-controlled, single dose crossover studies were performed. Active treatm...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 71; no. 10; pp. 1175 - 1185 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Springer Nature
Oct2015
|
| Acceso en línea: | Ver este registro en EBSCOhost |